[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cyp2d6-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"CYP2D6 Gene",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07565428","Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications",[11],"Phase 3","RECRUITING","2026-08-26T02:17:01.714035Z","2026-07-30T01:46:14.437259Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07204418","A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants",[19],"Phase 1","2026-08-26T02:16:21.385056Z","2026-05-05T02:43:29.713558Z"]